This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Keidar S, Guttmann H, Stam T, Fishman I, Shapira C.High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate. Pharmacoepidemiology and Drug Safety 16: 1192-1194, No. 11, Nov 2007
About this article
Cite this article
The use of fibric acid derivatives combined with rosiglitazone appears to decrease HDL cholesterol levels in patients with diabetes mellitus (DM). React. Wkly. 1184, 5 (2008). https://doi.org/10.2165/00128415-200811840-00017
- Public Health
- Diabetes Mellitus
- Cholesterol Level